Coller Capital Research
LPs sceptical about buyout returns
More on LPs
Nest mandates Schroders for PE strategy
Defined contribution workplace pension scheme is seeking exposure to growth and mid-market PE deals
LP Profile: Novo Ventures ready for steady deployment amid IPO lull
Danish biotech investor’s Naveed Siddiqi on opportunities arising from larger funding rounds and benefits of a two-pronged investment strategy
Pamplona to liquidate LetterOne-backed funds, to sell LP stakes in cut-off process
GP to begin formal wind down process on three funds after sanctions hit the LP’s Russian backers
ESG from ‘nice to have’ to prerequisite for almost all LPs – survey
Adams Street Partners’ 2022 Global Investor Survey gauged LPs’ views of 118 LPs globally
Latest News
FSN Capital acquires Epista Life Sciences
The GP said it will pursue a buy-and-build strategy in the life science IT services sector
Advent Life Sciences hires three partners
Dominic Schmidt is based in the UK, while Satish Jindal and Katrine Bosley join in the US
Five Arrows kicks off Laf Santé sale
Five Arrows has owned a majority stake in the France-based low-cost pharmacy chain since 2016
Hg’s MEDIFOX sale launch draws large-cap sponsor interest
Hg acquired the software platform for care providers in 2018 from ECM Equity Capital Management